ATE55900T1 - Feste pharmazeutische formulierungen mit ueber einen weiten bereich variablen langsamen freigabe nullter ordnung durch kontrollierte oberflaechenerosion. - Google Patents

Feste pharmazeutische formulierungen mit ueber einen weiten bereich variablen langsamen freigabe nullter ordnung durch kontrollierte oberflaechenerosion.

Info

Publication number
ATE55900T1
ATE55900T1 AT84401152T AT84401152T ATE55900T1 AT E55900 T1 ATE55900 T1 AT E55900T1 AT 84401152 T AT84401152 T AT 84401152T AT 84401152 T AT84401152 T AT 84401152T AT E55900 T1 ATE55900 T1 AT E55900T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
compound
oral compositions
compositions
wide range
Prior art date
Application number
AT84401152T
Other languages
English (en)
Inventor
David R Powell
Vithal K Patel
Original Assignee
Rowell Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowell Lab Inc filed Critical Rowell Lab Inc
Application granted granted Critical
Publication of ATE55900T1 publication Critical patent/ATE55900T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Sliding Valves (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
AT84401152T 1983-07-07 1984-06-06 Feste pharmazeutische formulierungen mit ueber einen weiten bereich variablen langsamen freigabe nullter ordnung durch kontrollierte oberflaechenerosion. ATE55900T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/511,605 US4539198A (en) 1983-07-07 1983-07-07 Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
EP84401152A EP0131485B1 (de) 1983-07-07 1984-06-06 Feste pharmazeutische Formulierungen mit über einen weiten Bereich variablen langsamen Freigabe nullter Ordnung durch kontrollierte Oberflächenerosion

Publications (1)

Publication Number Publication Date
ATE55900T1 true ATE55900T1 (de) 1990-09-15

Family

ID=24035636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84401152T ATE55900T1 (de) 1983-07-07 1984-06-06 Feste pharmazeutische formulierungen mit ueber einen weiten bereich variablen langsamen freigabe nullter ordnung durch kontrollierte oberflaechenerosion.

Country Status (14)

Country Link
US (1) US4539198A (de)
EP (1) EP0131485B1 (de)
AT (1) ATE55900T1 (de)
AU (1) AU561633B2 (de)
CA (1) CA1224417A (de)
DE (1) DE3483072D1 (de)
DK (1) DK162697C (de)
ES (1) ES8600053A1 (de)
FI (1) FI842528A7 (de)
IL (1) IL72089A (de)
IT (1) IT1180193B (de)
NO (1) NO170753C (de)
NZ (1) NZ208393A (de)
ZA (1) ZA845208B (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4851229A (en) * 1983-12-01 1989-07-25 Alza Corporation Composition comprising a therapeutic agent and a modulating agent
US4751071A (en) * 1983-12-01 1988-06-14 Alza Corporation Composition comprising salbutamol
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4631305A (en) * 1985-03-22 1986-12-23 The Upjohn Company Polymeric material as a disintegrant in a compressed tablet
WO1987001936A1 (fr) * 1985-09-25 1987-04-09 Gerhard Gergely Pastille de desintegration et son procede de fabrication
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US6482516B1 (en) * 1993-07-20 2002-11-19 Banner Pharmacaps, Inc. Enrobed tablet
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
US6726929B1 (en) 1998-12-18 2004-04-27 Basf Aktiengesellschaft Pharmaceutical mixture comprising a profen
HUP0104606A3 (en) * 1998-12-18 2003-01-28 Basf Ag A pharmaceutical mixture comprising a profen
US6210716B1 (en) 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
US8545880B2 (en) * 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
NZ517466A (en) 1999-09-02 2003-11-28 Nostrum Pharmaceuticals Inc Controlled release oral dosage suitable for oral administration
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
CA2420576C (en) 2000-08-29 2005-06-14 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
KR20040100835A (ko) * 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030190359A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
KR101203022B1 (ko) 2004-07-02 2012-11-21 가부시키가이샤 메이지 고형 우유, 및 그 제조 방법
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
EP1784166B1 (de) * 2004-09-01 2009-03-04 The Procter and Gamble Company Zusammensetzungen mit 5-amino-2-hydroxybenzoesäure und einem reduzierendem zucker
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1951266A2 (de) 2005-09-02 2008-08-06 Genzyme Corporation Verfahren zur entfernung von phosphat und dafür verwendetes polymer
KR101547925B1 (ko) 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
US20110165236A1 (en) * 2006-09-22 2011-07-07 Biokey, Inc. Controlled release hydrogel formulation
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
CA2704949A1 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Gastrointestinal delivery systems
EP2217215A1 (de) * 2007-12-14 2010-08-18 Genzyme Corporation Beschichtete pharmazeutische zusammensetzungen
EP2329823A4 (de) 2008-09-03 2013-04-03 Takeda Pharmaceutical Verfahren zur erhöhung der absorptionsfähigkeit eines präparats sowie präparat mit erhöhter absorptionsfähigkeit
EP2440210A4 (de) 2009-06-12 2014-01-29 Meritage Pharma Inc Verfahren zur behandlung von magen-darm-erkrankungen
BR112012027782A2 (pt) 2010-04-30 2016-08-02 Takeda Pharmaceutical tablete entérico
KR101820181B1 (ko) 2010-04-30 2018-02-28 다케다 야쿠힌 고교 가부시키가이샤 장용성 정제
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
EP2425826A1 (de) 2010-09-01 2012-03-07 Disphar International B.V. Mesalazin-Tablette mit verbesserter Auflösung
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
ITUA20162293A1 (it) 2016-04-05 2017-10-05 Sofar Spa Processo per formulazioni solide di mesalazina
EP3662898A1 (de) * 2018-12-07 2020-06-10 Tillotts Pharma AG Feste formulierung enthaltend mesalazin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration

Also Published As

Publication number Publication date
ES534096A0 (es) 1985-10-01
FI842528A7 (fi) 1985-01-08
AU2889884A (en) 1985-01-10
IL72089A (en) 1987-09-16
IT1180193B (it) 1987-09-23
DE3483072D1 (de) 1990-10-04
US4539198A (en) 1985-09-03
FI842528A0 (fi) 1984-06-21
NZ208393A (en) 1987-03-31
DK333884A (da) 1985-01-08
EP0131485B1 (de) 1990-08-29
IT8421720A0 (it) 1984-07-02
NO842766L (no) 1985-01-08
NO170753B (no) 1992-08-24
DK333884D0 (da) 1984-07-06
DK162697C (da) 1992-04-21
CA1224417A (en) 1987-07-21
AU561633B2 (en) 1987-05-14
ZA845208B (en) 1985-03-27
EP0131485A3 (en) 1986-08-06
IL72089A0 (en) 1984-10-31
EP0131485A2 (de) 1985-01-16
IT8421720A1 (it) 1986-01-02
DK162697B (da) 1991-12-02
NO170753C (no) 1992-12-02
ES8600053A1 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
ATE55900T1 (de) Feste pharmazeutische formulierungen mit ueber einen weiten bereich variablen langsamen freigabe nullter ordnung durch kontrollierte oberflaechenerosion.
IT1282352B1 (it) Composizione farmaceutica, in particolare essiccata mediante congelamento, per somministrazione orale di ondansetron e metodo per
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
DK0385582T3 (da) Nifedipin-holdige farmaceutiske præparater og fremgangsmåde til fremstilling heraf
SE8406081L (sv) Sett och komposition for framstellning av farmaceutiska preparat for oral administrering och med kontrollerad langtidsverkan
BG105436A (en) Pharmaceutical compositions comprising entacapone or nitecapone as well as a cross-linked cellulpse derivative
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
PT98758A (pt) Processo para a preparacao de uma composicao sob a forma de comprimido ou drageia contendo um ingrediente activo de preferencia um derivado de aminoguanidina sensivel ao calor luz e humidade tendo estretura cristalina monoclinica
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
FI955837A0 (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
GB1354451A (en) Halogen-substituted phenyl-alkylamines and their derivatives
MX9307009A (es) Derivados de 5-[(imidaol{4,5-b}piridin-3-il]metil/benzofurano, procesopara su preparacion y composiciones farmaceuticas que los contienen.
EP0348664A3 (de) Monoacetoacetine enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Tumoren
SE9001592L (sv) Terapeutisk komposition
KR910007526A (ko) 인터류킨-1 생합성 억제제로의 3-치화된-2-옥신돌 유도체
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
GB1091134A (en) Pharmaceutical and veterinary compositions comprising a sorbitol acetal
GB1485382A (en) Injectable therapeutic compositions
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
TH59782A3 (th) สารผสมของกาแลนแทมีนชนิดปลดปล่อยที่มีการควบคุม
EP0530016A3 (de) Piperidinderivat und dieses enthaltende pharmazeutische Zubereitung
ITMI911653A1 (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee